» Articles » PMID: 3548427

Effects of Insulin on Hexose Transport Across Blood-brain Barrier in Normoglycemia

Overview
Journal Am J Physiol
Specialty Physiology
Date 1987 Mar 1
PMID 3548427
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of insulin on 3-O-[14C]methylglucose transport across the blood-brain barrier (BBB) were studied in conscious rats under steady-state normoglycemic conditions. The [14C]methylglucose was infused intravenously at a constant rate, and animals were killed at various times between 5 and 30 min after the initiation of the infusion. The time course of the arterial plasma concentration of [14C]methylglucose was determined in timed arterial blood samples taken during the infusion. Local cerebral tissue concentrations of [14C]methylglucose at the time of killing were determined by quantitative autoradiography of brain sections. The rate constants for inward and outward transport of [14C]methylglucose across the BBB, K1, and k2, respectively, were estimated by a least-squares, best-fit of a kinetic equation to the measured time courses of plasma and tissue concentrations. K1 and k2 were reduced by an average of 24 and 31%, respectively, in gray matter and 7 and 16% in white matter from values estimated similarly in normal insulinemic control rats. The equilibrium distribution ratio, K1/k2, for [14C]methylglucose in brain increased by approximately 10-11% in the hyperinsulinemic animals. Because 3-O-[14C]methylglucose shares the same carrier that transports glucose and other hexoses across the BBB, these results suggest that hyperinsulinemia decreases the rate constants for transport but increases the distribution space for hexoses in brain. These effects are, however, quite small and are probably minor or negligible when compared with the major effects of insulin in other tissues.

Citing Articles

Nicotine pre-exposure reduces stroke-induced glucose transporter-1 activity at the blood-brain barrier in mice.

Shah K, Boreddy P, Abbruscato T Fluids Barriers CNS. 2015; 12:10.

PMID: 25925411 PMC: 4425877. DOI: 10.1186/s12987-015-0005-y.


Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia.

Gejl M, Egefjord L, Lerche S, Vang K, Bibby B, Holst J J Cereb Blood Flow Metab. 2012; 32(12):2146-52.

PMID: 22929437 PMC: 3519409. DOI: 10.1038/jcbfm.2012.118.


The rate-limiting step for glucose transport into the hypothalamus is across the blood-hypothalamus interface.

Poitry-Yamate C, Lei H, Gruetter R J Neurochem. 2009; 109 Suppl 1:38-45.

PMID: 19393007 PMC: 2679176. DOI: 10.1111/j.1471-4159.2009.05934.x.


Cognitive dysfunction and diabetes mellitus.

Kodl C, Seaquist E Endocr Rev. 2008; 29(4):494-511.

PMID: 18436709 PMC: 2528851. DOI: 10.1210/er.2007-0034.


In normal rat, intraventricularly administered insulin-like growth factor-1 is rapidly cleared from CSF with limited distribution into brain.

Nagaraja T, Patel P, Gorski M, Gorevic P, Patlak C, Fenstermacher J Cerebrospinal Fluid Res. 2005; 2:5.

PMID: 16045806 PMC: 1190198. DOI: 10.1186/1743-8454-2-5.